Clinical Trial Update: A Study Evaluating the Safety, Tolerability, and Activity of ICM-203 in Subjects With Knee Osteoarthritis. [Phase 1, Phase 2]

View source ↗

Summary

A registered clinical trial assessing safety, tolerability, and activity of ICM-203 in knee osteoarthritis, currently in Phase 1/2 and not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis Knee

Drugs mentioned

• ICM-203 (ICM-203)

Snippet

Sponsor: ICM Co. Ltd. | Conditions: Osteoarthritis, Knee | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING